Orthocare Innovations Acquires StepWatch™ and IP Assets from Seattle-Based Cyma Corporation.
October 01, 2007
Orthocare Innovations, a research and development company focused on the commercialization of rehabilitation and aging technologies, announced today that it has acquired the assets of Cyma Corporation. Included in the transaction are exclusive rights to the patented StepWatch™ activity monitoring technology, and patent-pending Compas™, revolutionary prosthetic device technology developed with research support from the National Institutes of Health
StepWatch™ is widely recognized as the industry-leading, most highly accurate step activity monitor. Academic medical centers, universities, and increasingly, pharmaceutical companies and clinical research organizations, utilize StepWatch™ extensively. StepWatch™ customers include:
- Mayo Clinic
- Duke University
- U.S. Department of Defense
- Cornell University
- Shriners Hospitals for Children
- Arthritis Foundation
- Columbia University
- Moss Rehabilitation Research Institute
- Washington University
- U.S. Department of Veterans Affairs
- Massachusetts General Hospital
- University of Pittsburgh
- University of Washington
Copyright © 2007 - 2012 Orthocare Innovations, LLC. All rights reserved.